Selenium as a therapeutic adjuvant for isoniazid/rifampicin-induced hepatotoxicity
BACKGROUND: Isoniazid-rifampicin (INH-RIF) is used for the treatment of tuberculosis, but its hepatotoxicity is a serious health predicament. Selenium (Se) is a trace element with potential to safeguard cells from damage. AIM AND OBJECTIVE: This study assessed the potential of Se to prevent INH/RIF-...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
| Series: | BLDE University Journal of Health Sciences |
| Subjects: | |
| Online Access: | http://www.bldeujournalhs.in/article.asp?issn=2468-838X;year=2020;volume=5;issue=1;spage=60;epage=67;aulast=Adikwu |